Navigene is a leading brand specializing in screening, diagnosis, and research in the field of Metabolomics. With a team of skilled scientists and advanced technologies, Navigene aims to provide early and accurate prediction/diagnosis of disorders and ailments. Their preventive genetic screening solution is designed for newborns, children, and adults, and offers highly customized and tailored services to hospitals, laboratories, institutions, clients, and regions.

One of Navigene's flagship products is NAVIGENE BABY SCREEN, which uses an innovative technology to screen newborn babies for 110 genetic and metabolic disorders as early as the 3rd day of life. This comprehensive screening test is conducted using just a urine sample collected on a special filter paper, making it convenient and non-invasive. Navigene takes pride in being the first Indian company in the genetics and metabolomics field to export its technology and establish a world-class facility in South East Asia.

They have also developed a successful model for overseas expansion and service delivery, collaborating with strategic partners and laboratories in different countries and regions. With affordable prices and a commitment to mass-scale implementation, Navigene is dedicated to making their unique services accessible to a wide range of individuals and institutions worldwide